Advertisement
Review Article| Volume 26, ISSUE 1, P13-30, March 2006

Utilizing the Laboratory in the Poisoned Patient

      When evaluating an intoxicated patient, there is no substitute for a thorough history and physical examination. Numerous medical shows on television depict a universal toxicology screen that automatically determines the agent causing a patient's symptoms. Samples cannot be simply “sent to the lab,” however, with the correct diagnosis to a clinical mystery returning on a computer printout. Clues from a patient's physical examination are generally more likely to be helpful than a “shotgun” laboratory approach that involves indiscriminate testing of blood or urine for multiple agents.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wu A.H.
        • McKay C.
        • Broussard L.A.
        • et al.
        National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department.
        Clin Chem. 2003; 49: 357-379
        • Temple A.R.
        Acute and chronic effects of aspirin toxicity and their treatment.
        Arch Intern Med. 1981; 141: 364-369
        • Flomenbaum N.E.
        Salicylates.
        in: Goldfrank L.R. Flomenbaum N.E. Lewin N.A. Goldfrank's toxicologic emergencies. 7th ed. McGraw-Hill, New York2002: 507-527
        • Nordt S.P.
        Diflunisal cross-reactivity with the Trinder method for salicylate determination.
        Ann Pharmacother. 1996; 30: 1041-1042
        • Dalrymple R.W.
        • Stearns F.M.
        Diflunisal interference with determination of salicylate by the Trinder, Abbott TDx, and Du Pont aca methods.
        Clin Chem. 1986; 32: 230
        • Adelman H.M.
        • Wallach P.M.
        • Flannery M.T.
        Inability to interpret toxic salicylate levels in patients taking aspirin and diflunisal.
        J Rheumatol. 1991; 18: 522-523
        • Szucs P.A.
        • Shih R.D.
        • Marcus S.M.
        • et al.
        Pseudosalicylate poisoning: falsely elevated salicylate levels in an overdose of diflunisal.
        Am J Emerg Med. 2000; 18: 641-642
        • Duffens K.R.
        • Smilkstein M.J.
        • Bessen H.A.
        • Rumack B.H.
        Falsely elevated salicylate levels due to diflunisal overdose.
        J Emerg Med. 1987; 5: 499-503
        • Berkovitch M.
        • Uziel Y.
        • Greenberg R.
        • et al.
        False-high blood salicylate levels in neonates with hyperbilirubinemia.
        Ther Drug Monit. 2000; 22: 757-761
        • Done A.K.
        Salicylate intoxication: significance of measurements of salicylate in blood in cases of acute ingestion.
        Pediatrics. 1960; 26: 800-807
        • Needs C.J.
        • Brooks P.M.
        Clinical pharmacokinetics of the salicylates.
        Clin Pharmacokinet. 1985; 10: 164-177
        • Dugandzic R.M.
        • Tierney M.G.
        • Dickinson G.E.
        • et al.
        Evaluation of the validity of the Done nomogram in the management of acute salicylate intoxication.
        Ann Emerg Med. 1989; 18: 1186-1190
        • Chapman B.J.
        • Proudfoot A.T.
        Adult salicylate poisoning: deaths and outcome in patients with high plasma salicylate concentrations.
        QJM. 1989; 72: 699-707
        • Hahn I.H.
        • Chu J.
        • Hoffman R.S.
        • Nelson L.S.
        Errors in reporting salicylate levels.
        Acad Emerg Med. 2000; 7: 1336-1337
        • Krenzelok E.P.
        • Guharoy S.L.
        • Johnson D.R.
        Toxicology screening in the emergency department: ethanol, barbiturates, and salicylates.
        Am J Emerg Med. 1984; 2: 331-332
        • Chan T.Y.
        • Chan A.Y.
        • Ho C.S.
        • Critchley J.A.
        The clinical value of screening for salicylates in acute poisoning.
        Vet Hum Toxicol. 1995; 37: 37-38
        • Chan T.Y.
        • Chan A.Y.
        Use of a plasma salicylate assay service in a medical unit in Hong Kong: a follow-up study.
        Vet Hum Toxicol. 1996; 38: 278-279
        • Sporer K.A.
        • Khayam-Bashi H.
        Acetaminophen and salicylate serum levels in patients with suicidal ingestion or altered mental status.
        Am J Emerg Med. 1996; 14: 443-446
        • Leatherman J.W.
        • Schmitz P.G.
        Fever, hyperdynamic shock, and multiple-system organ failure: a pseudo-sepsis syndrome associated with chronic salicylate intoxication.
        Chest. 1991; 100: 1391-1396
        • Chui P.T.
        Anesthesia in a patient with undiagnosed salicylate poisoning presenting as intraabdominal sepsis.
        J Clin Anesth. 1999; 11: 251-253
        • Paul B.N.
        Salicylate poisoning in the elderly: diagnostic pitfalls.
        J Am Geriatr Soc. 1972; 20: 387-390
        • Anderson R.J.
        • Potts D.E.
        • Gabow P.A.
        • et al.
        Unrecognized adult salicylate intoxication.
        Ann Intern Med. 1976; 85: 745-748
        • McGuigan M.A.
        A two-year review of salicylate deaths in Ontario.
        Arch Intern Med. 1987; 147: 510-512
        • Halla J.T.
        • Atchison S.L.
        • Hardin J.G.
        Symptomatic salicylate ototoxicity: a useful indicator of serum salicylate concentration?.
        Ann Rheum Dis. 1991; 50: 682-684
        • Bailey R.B.
        • Jones S.R.
        Chronic salicylate intoxication: a common cause of morbidity in the elderly.
        J Am Geriatr Soc. 1989; 37: 556-561
      1. Baer A, Holstege C, Eldridge D. Serum bicarbonate as a predictor of toxic salicylate levels. Presented at the European Association of Poison Centres and Clinical Toxicologists 25th International Congress. Berlin, Germany, 2005.

        • Bizovi K.E.
        • Smilkstein M.J.
        Acetaminophen.
        in: Goldfrank L.R. Flomenbaum N.E. Lewin N.A. Goldfrank's toxicologic emergencies. 7th ed. McGraw-Hill, New York2002: 480-501
        • Smilkstein M.J.
        • Knapp G.L.
        • Kulig K.W.
        • Rumack B.H.
        Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study (1976 to 1985).
        N Engl J Med. 1988; 319: 1557-1562
        • Ashbourne J.F.
        • Olson K.R.
        • Khayam-Bashi H.
        Value of rapid screening for acetaminophen in all patients with intentional drug overdose.
        Ann Emerg Med. 1989; 18: 1035-1038
        • Chan T.Y.
        • Chan A.Y.
        • Ho C.S.
        • Critchley J.A.
        The clinical value of screening for paracetamol in patients with acute poisoning.
        Hum Exp Toxicol. 1995; 14: 187-189
        • Dargan P.I.
        • Ladhani S.
        • Jones A.L.
        Measuring plasma paracetamol concentrations in all patients with drug overdose or altered consciousness: does it change outcome?.
        Emerg Med J. 2001; 18: 178-182
        • Hartington K.
        • Hartley J.
        • Clancy M.
        Measuring plasma paracetamol concentrations in all patients with drug overdoses: development of a clinical decision rule and clinicians willingness to use it.
        Emerg Med J. 2002; 19: 408-411
        • Suchard J.R.
        Osmolal gap.
        in: Dart R.C. Medical toxicology. 3rd ed. Lippincott Williams & Wilkins, Philadelphia2004: 106-109
        • Kruse J.A.
        • Cadnapaphornchai P.
        The serum osmole gap.
        J Crit Care. 1994; 9: 185-197
        • Erstad B.L.
        Osmolality and osmolarity: narrowing the terminology gap.
        Pharmacotherapy. 2003; 23: 1085-1086
        • Glaser D.S.
        Utility of the serum osmol gap in the diagnosis of methanol or ethylene glycol ingestion.
        Ann Emerg Med. 1996; 27: 343-346
        • Worthley L.I.
        • Guerin M.
        • Pain R.W.
        For calculating osmolality, the simplest formula is the best.
        Anaesth Intensive Care. 1987; 15: 199-202
        • Hoffman R.S.
        • Smilkstein M.J.
        • Howland M.A.
        • Goldfrank L.R.
        Osmol gaps revisited: normal values and limitations.
        J Toxicol Clin Toxicol. 1993; 31: 81-93
        • Smithline N.
        • Gardner Jr., K.D.
        Gaps—anionic and osmolal.
        JAMA. 1976; 236: 1594-1597
        • Glasser L.
        • Sternglanz P.D.
        • Combie J.
        • Robinson A.
        Serum osmolality and its applicability to drug overdose.
        Am J Clin Pathol. 1973; 60: 695-699
        • McQuillen K.K.
        • Anderson A.C.
        Osmol gaps in the pediatric population.
        Acad Emerg Med. 1999; 6: 27-30
        • Aabakken L.
        • Johansen K.S.
        • Rydningen E.B.
        • et al.
        Osmolal and anion gaps in patients admitted to an emergency medical department.
        Hum Exp Toxicol. 1994; 13: 131-134
        • Darchy B.
        • Abruzzese L.
        • Pitiot O.
        • et al.
        Delayed admission for ethylene glycol poisoning: lack of elevated serum osmol gap.
        Intensive Care Med. 1999; 25: 859-861
        • Steinhart B.
        Case report: severe ethylene glycol intoxication with normal osmolal gap—“a chilling thought”.
        J Emerg Med. 1990; 8: 583-585
        • Chabali R.
        Diagnostic use of anion and osmolal gaps in pediatric emergency medicine.
        Pediatr Emerg Care. 1997; 13: 204-210
        • Ishihara K.
        • Szerlip H.M.
        Anion gap acidosis.
        Semin Nephrol. 1998; 18: 83-97
        • Gabow P.A.
        Disorders associated with an altered anion gap.
        Kidney Int. 1985; 27: 472-483
        • Hoffman R.J.
        • Nelson L.S.
        • Hoffman R.S.
        Use of ferric chloride to identify salicylate-containing poisons.
        J Toxicol Clin Toxicol. 2002; 40: 547-549
        • King J.A.
        • Storrow A.B.
        • Finkelstein J.A.
        Urine Trinder spot test: a rapid salicylate screen for the emergency department.
        Ann Emerg Med. 1995; 26: 330-333
        • Ford M.
        • Tomaszewski C.
        • Kerns W.
        • et al.
        Bedside ferric chloride urine test to rule out salicylate intoxication.
        Vet Hum Toxicol. 1994; 36: 364
        • Weiner A.L.
        • Ko C.
        • McKay Jr., C.A.
        A comparison of two bedside tests for the detection of salicylates in urine.
        Acad Emerg Med. 2000; 7: 834-836
        • Wallace K.L.
        • Suchard J.R.
        • Curry S.C.
        • Reagan C.
        Diagnostic use of physicians' detection of urine fluorescence in a simulated ingestion of sodium fluorescein-containing antifreeze.
        Ann Emerg Med. 2001; 38: 49-54
        • Winter M.L.
        • Ellis M.D.
        • Snodgrass W.R.
        Urine fluorescence using a Wood's lamp to detect the antifreeze additive sodium fluorescein: a qualitative adjunctive test in suspected ethylene glycol ingestions.
        Ann Emerg Med. 1990; 19: 663-667
        • Casavant M.J.
        • Shah M.N.
        • Battels R.
        Does fluorescent urine indicate antifreeze ingestion by children?.
        Pediatrics. 2001; 107: 113-114
        • Kellermann A.L.
        • Fihn S.D.
        • LoGerfo J.P.
        • Copass M.K.
        Impact of drug screening in suspected overdose.
        Ann Emerg Med. 1987; 16: 1206-1216
        • Mahoney J.D.
        • Gross P.L.
        • Stern T.A.
        • et al.
        Quantitative serum toxic screening in the management of suspected drug overdose.
        Am J Emerg Med. 1990; 8: 16-22
        • Brett A.
        Toxicologic analysis in patients with drug overdose.
        Arch Intern Med. 1988; 148: 2077
        • Bast R.P.
        • Helmer S.D.
        • Henson S.R.
        • et al.
        Limited utility of routine drug screening in trauma patients.
        South Med J. 2000; 93: 397-399
        • Fabbri A.
        • Marchesini G.
        • Morselli-Labate A.M.
        • et al.
        Comprehensive drug screening in decision making of patients attending the emergency department for suspected drug overdose.
        Emerg Med J. 2003; 20: 25-28
        • Milzman D.P.
        • Boulanger B.R.
        • Rodriguez A.
        • et al.
        Pre-existing disease in trauma patients: a predictor of fate independent of age and injury severity score.
        J Trauma. 1992; 32: 236-243
        • Perrone J.
        • De Roos F.
        • Jayaraman S.
        • Hollander J.E.
        Drug screening versus history in detection of substance use in ED psychiatric patients.
        Am J Emerg Med. 2001; 19: 49-51
        • George S.
        • Braithwaite R.A.
        A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening.
        Addiction. 1995; 90: 227-232
        • Gennari F.J.
        Current concepts: serum osmolality: uses and limitations.
        N Engl J Med. 1984; 310: 102-105
        • Sklar A.H.
        • Linas S.L.
        The osmolal gap in renal failure.
        Ann Intern Med. 1983; 98: 481-482
        • Yaucher N.E.
        • Fish J.T.
        • Smith H.W.
        • Wells J.A.
        Propylene glycol-associated renal toxicity from lorazepam infusion.
        Pharmacotherapy. 2003; 23: 1094-1099
        • Schelling J.R.
        • Howard R.L.
        • Winter S.D.
        • Linas S.L.
        Increased osmolal gap in alcoholic ketoacidosis and lactic acidosis.
        Ann Intern Med. 1990; 113: 580-582
        • Seifert S.A.
        Unexplained acid-base and anion gap disorders.
        in: Dart R.C. Medical toxicology. 3rd edition. Lippincott Williams & Wilkins, Philadelphia2004: 43-51